Aware, Inc. (NASDAQ: AWRE) will host a webcast on Wednesday, April 29, 2026, at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2026. Financial results will be released via press release prior to the call, which will include a Q&A session with management. Interested parties can register for the webcast online or submit questions in advance via email.

AeroVironment (AV) announced that its precision pointing hardware was crucial for the Artemis II Mission's Orion Artemis II Optical Communications System (O2O). This technology enabled the precise aiming of a laser communications terminal, allowing high-resolution video and images to be sent from lunar orbit to Earth at significantly faster speeds than traditional radio systems. AV's contribution, including a two-axis gimbal and fast steering mirrors, underlines its expertise in advanced electro-optical systems for challenging space environments.

eBay Inc. (EBAY) stock price has shown gains and is attacking the key resistance level of $100.00, supported by trading above its 50-day SMA and a strong medium-term bullish trend. Positive signals from the Stochastic indicator suggest further upside. The forecast predicts continued stock price rise, especially if the $100.00 resistance is broken, with a target of $108.00.

Amgen Inc. stands out in the biotech sector due to its focus on biologics, a strong pipeline of innovative therapies, and an established portfolio of blockbuster drugs. The company’s business model centers on developing high-value biologics with long market exclusivity, supported by robust R&D spending and shareholder returns. Amgen maintains a competitive edge through its strong patent portfolio and strategic expansion into high-growth areas, making it an attractive option for investors seeking stability and growth in healthcare.

Intuit Inc. exhibits a resilient business model centered on indispensable financial software for small businesses and individuals, offering a blend of growth and stability through its strong subscription-based services like QuickBooks and TurboTax. The company's focus on essential services, high user retention, AI integration, and strategic emphasis on deepening SMB penetration and expanding financial services ecosystems positions it as a compelling long-term holding for investors in English-speaking markets. Despite risks from competition and macro slowdowns, Intuit's proven track record and competitive moat provide a strong basis for continued growth and shareholder value.

The National Hockey League (NHL) has secured a new multi-year partnership with Procter & Gamble (P&G) in Canada, launching ahead of the 2026 Stanley Cup Playoffs. This collaboration integrates several P&G brands, including Gillette, Old Spice, Tide, and Downy Rinse, into fan-centric NHL programming. The partnership aims to engage fans through various initiatives at home and at the rink, reinforcing hockey's cultural significance in Canada.

Phocas Financial Corp. has acquired a new stake of 146,869 shares in Commercial Bancgroup, Inc. (NASDAQ:CBK) during the fourth quarter, valued at approximately $3.61 million. This acquisition represents about 1.20% ownership of Commercial Bancgroup, with other institutions also increasing their holdings. Analyst opinions are mixed, with a "sell" rating from Weiss Ratings but a "Moderate Buy" consensus from MarketBeat.

CACI International Inc (NYSE: CACI) has been awarded a five-year task order worth over $306 million to enhance the Defense Agencies Initiative's Global Model for the Defense Logistics Agency. This contract highlights CACI's role in modernizing financial processes within the Department of Defense and supporting national security. Despite strong growth potential and profitability indicated by its GF Score™ of 95/100, insider selling activity totaling $1.4 million in the last three months suggests a need for investor caution.

The Progressive Corporation reported a 6% increase in Q1 net premiums written, reaching $23.64 billion, and a 10% rise in net income to $2.82 billion. Earnings per share also grew by 10% to $4.80. The company's profitability and undervalued stock status, as suggested by InvestingPro, are highlighted alongside policy growth across various lines of business.

Truist has lowered its price target for Insulet (NASDAQ: PODD) to $315 from $360, while maintaining a Buy rating on the stock. This adjustment follows similar actions by other firms like RBC, BTIG Research, and Goldman Sachs, who have also reduced their price targets for Insulet recently, though mostly retaining favorable ratings. Insulet specializes in medical devices for insulin-dependent diabetes and non-insulin drug delivery systems.